TY - CHAP
T1 - Down syndrome and Alzheimer disease
T2 - A "multi-hit" hypothesis based on multiple contributing factors resulting in pleotrophic consequences
AU - Bonda, David J.
AU - Castellani, Rudy J.
AU - Lee, Hyoung Gon
AU - Tabaton, Massimo
AU - Casadesus, Gemma
AU - Perry, George
AU - Zhu, Xiongwei
AU - Smith, Mark A.
N1 - Publisher Copyright:
© 2013 by Nova Science Publishers, Inc. All rights reserved.
PY - 2013/1/1
Y1 - 2013/1/1
N2 - While dogma and orthodoxy view amyloid-β as the primary mediator of Alzheimertype symptomology and neuropathology in Down syndrome, there are significant reasons to question this. In this commentary, we not only demolish the foundations of this orthodoxy, but rebuild an entirely new mechanism. Our multi-hit system is centered on the key contributions of oxidative stress, hormonal imbalance, and cardiovascular dysfunction that interact to deliver a one-two knockout blow eliciting neuropathological lesions, neuronal death, and ultimately, cognitive decline. This multi-hit hypothesis of Alzheimer-type pathology and degeneration in Down syndrome not only explains the apparent failure of targeted the rapeutics, but will foster the development of novel mechanistic and pharmacological approaches toward future treatment and therapeutic strategies.
AB - While dogma and orthodoxy view amyloid-β as the primary mediator of Alzheimertype symptomology and neuropathology in Down syndrome, there are significant reasons to question this. In this commentary, we not only demolish the foundations of this orthodoxy, but rebuild an entirely new mechanism. Our multi-hit system is centered on the key contributions of oxidative stress, hormonal imbalance, and cardiovascular dysfunction that interact to deliver a one-two knockout blow eliciting neuropathological lesions, neuronal death, and ultimately, cognitive decline. This multi-hit hypothesis of Alzheimer-type pathology and degeneration in Down syndrome not only explains the apparent failure of targeted the rapeutics, but will foster the development of novel mechanistic and pharmacological approaches toward future treatment and therapeutic strategies.
UR - http://www.scopus.com/inward/record.url?scp=84933035932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84933035932&partnerID=8YFLogxK
M3 - Chapter
AN - SCOPUS:84933035932
SN - 9781622575107
SP - 183
EP - 193
BT - Alzheimer's Disease Research Compendium
PB - Nova Science Publishers, Inc.
ER -